NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com

Research analysts at StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note issued on Saturday. The brokerage set a “sell” rating on the medical device company’s stock.

NeuroMetrix Trading Down 3.8 %

Shares of NURO stock opened at $4.30 on Friday. The company has a market cap of $8.56 million, a PE ratio of -0.69 and a beta of 2.28. NeuroMetrix has a 12-month low of $2.70 and a 12-month high of $9.87. The business’s fifty day simple moving average is $4.02 and its 200-day simple moving average is $3.73.

NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings results on Thursday, February 22nd. The medical device company reported ($1.43) EPS for the quarter. The business had revenue of $1.32 million during the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 31.31%.

Hedge Funds Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC acquired a new position in NeuroMetrix, Inc. (NASDAQ:NURO) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent quarter. 19.40% of the stock is owned by hedge funds and other institutional investors.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.